Title: Vandetanib plus pemetrexed vs pemetrexed as 2nd-line therapy in patients with advanced non-small-cell lung cancer (NSCLC); a randomized, double-blind phase III trial
Authors: Vansteenkiste, Johan
Arrieta, O
Gottfried, M
Blackhall, F. H
Raats, J
Yang, C. H
Langmuir, P
Milenkova, T
Read, J
de Boer, R. H #
Issue Date: Sep-2009
Publisher: Pergamon/Elsevier
Host Document: European Journal of Cancer Supplements vol:7 issue:2 pages:506-506
Conference: - edition:- location:- date:-
ISSN: 1359-6349
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Pneumology
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.